Workflow
棒杰股份(002634) - 2017 Q1 - 季度财报
BANGJIE SHAREBANGJIE SHARE(SZ:002634)2017-04-24 16:00

Revenue and Profit - Revenue for Q1 2017 was ¥79,802,509.02, a decrease of 17.70% compared to ¥96,968,579.89 in the same period last year[8] - Net profit attributable to shareholders was ¥8,042,486.08, down 32.97% from ¥11,998,438.63 year-on-year[8] - Basic earnings per share decreased by 33.33% to ¥0.02 from ¥0.03 in the same period last year[8] - Net profit decreased by 33.72% to ¥10,151,406.61, mainly due to a reduction in operating income[17] - The company plans to achieve a net profit range of ¥1,822.19 to ¥2,465.31 million for the first half of 2017[22] Cash Flow - Net cash flow from operating activities increased by 50.51% to ¥16,925,431.97, compared to ¥11,245,279.10 in the previous year[8] - Cash flow from operating activities increased by 50.51% to ¥16,925,431.97, attributed to lower cash payments for goods and services[17] - Investment cash flow decreased by 167.16% to -¥28,463,298.01 due to increased investment expenditures by a subsidiary[17] Assets and Shareholder Equity - Total assets at the end of the reporting period were ¥1,102,239,820.64, reflecting a 0.84% increase from ¥1,093,031,536.18 at the end of the previous year[8] - Net assets attributable to shareholders increased by 1.21% to ¥673,667,400.55 from ¥665,624,914.47 at the end of the previous year[8] - Accounts receivable increased by 43.38% to ¥47,641,570.28 due to new orders in the current period[16] - Other receivables decreased by 73.68% to ¥8,076,512.45 primarily due to the recovery of deposits from a subsidiary[16] - Long-term equity investments rose by 61.98% to ¥81,010,031.51, reflecting new investments by a subsidiary[16] - The company reported a 47.87% increase in investment properties to ¥20,602,685.68, driven by new rental properties[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 49,276[11] - The largest shareholder, Tao Jianwei, holds 37.50% of the shares, amounting to 172,867,500 shares, with 129,650,623 shares pledged[11] - The company did not engage in any repurchase transactions during the reporting period[12] Financial Expenses and Gains - The company reported non-recurring gains and losses totaling ¥1,686.15 for the period[9] - Financial expenses increased by 199.66% to ¥544,114.05 due to reduced interest income from bank deposits[16] Investment Activities - The company is participating in the establishment of a medical industry equity investment fund through its wholly-owned subsidiary[18]